D.J. St. Germain’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History

D.J. St. Germain’s Portfolio IMPL Stock Details IMPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,500	Closed	-$185	–	847
2023 Q4	$185	Hold	1,500	–	–	﹤0.01%	757
2023 Q3	$645	Hold	1,500	–	–	﹤0.01%	709
2023 Q2	$1.91K	Buy	+1,500	New	+$2.27K	﹤0.01%	649

D.J. St. Germain's IMPL Position: Q1 2024 in Review

D.J. St. Germain sold out of Impel Pharmaceuticals Inc. Common Stock (IMPL) in Q1 2024, closing a stake of 1,500 shares — an estimated $185 sold.

D.J. St. Germain first reported a position in IMPL in Q2 2023 and held it in 3 quarters. The position peaked at $1.91K in Q2 2023. 0 funds tracked by Wall St. Rank hold IMPL as of Q1 2024.

D.J. St. Germain reported no remaining Impel Pharmaceuticals Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
D.J. St. Germain sold 1,500 Impel Pharmaceuticals Inc. Common Stock shares in Q1 2024, an estimated $185.
D.J. St. Germain first reported a position in Impel Pharmaceuticals Inc. Common Stock in Q2 2023 and held it in 3 quarters.
D.J. St. Germain's Impel Pharmaceuticals Inc. Common Stock position peaked at $1.91K in Q2 2023.
0 funds tracked by Wall St. Rank held Impel Pharmaceuticals Inc. Common Stock as of Q1 2024.

Based on D.J. St. Germain's 13F filing for Q1 2024, filed 2 Apr 2024.